Cy3 NHS ester, 5 mg

Hazard statements (CLP)

H302, H312, H317, H332, H334

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

1272/2008]

Product definition

Mono-constituent substance

CLP CLASSIFICATION

Acute Tox. 4, H302 Acute Tox. 4, H312 Acute Tox. 4, H332 Resp. Sens. 1, H334 Skin Sens. 1, H317 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.

Signal word

Danger

Hazard statements

Harmful if swallowed, in contact with skin or if inhaled. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction.

Prevention

Wear protective gloves. Wear protective clothing. Avoid breathing dust.

Response

IF INHALED: Remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or physician.

Storage

Not applicable.

Disposal

Dispose of contents and container in accordance with all local, regional, national and international regulations.

Supplemental label elements

Not applicable. Annex XVII - Restrictions on the Not applicable. manufacture, placing on the market and use of certain dangerous substances, mixtures and articles

Special packaging requirements

Containers to be fitted with Not applicable. child-resistant fastenings

Tactile warning of danger

Not applicable.

2.3 Other hazards

Product meets the criteria for PBT or vPvB according to Regulation (EC) No. 1907/2006, Annex XIII

PBT Substances

P B T

vPvB Substances

vP vB No N/A No N/A

Other hazards which do not result in classification

None known.